Dr. David Goldfarb, MD
What this data tells you about Dr. Goldfarb
Dr. David Goldfarb is an urology physician in Houston, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Goldfarb performed 5,953 Medicare services across 3,422 unique beneficiaries.
Between the years covered by Open Payments, Dr. Goldfarb received a total of $25,908 from 70 pharmaceutical and/or device companies across 592 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Goldfarb is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month | 1,316 | $46 | $65 |
| Office visit, established patient (30-39 min) | 1,252 | $91 | $135 |
| Blood draw (venipuncture) | 657 | $8 | $8 |
| Leuprolide injectable, camcevi, 1 mg | 546 | $63 | $80 |
| Bladder ultrasound after voiding | 270 | $8 | $11 |
| Automated urinalysis | 268 | $2 | $2 |
| Electronic assessment of bladder emptying | 228 | $6 | $15 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 189 | $298 | $387 |
| Insertion of device into abdomen with pressure and urine flow rate study | 187 | $159 | $201 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 155 | $27 | $68 |
| New patient office visit (45-59 min) | 144 | $109 | $173 |
| Diagnostic exam of bladder and urethra using an endoscope | 79 | $56 | $250 |
| Telephone medical discussion with physician, 21-30 minutes | 68 | $96 | $131 |
| Injection, garamycin, gentamicin, up to 80 mg | 57 | $2 | $3 |
| Biopsy of prostate gland | 55 | $95 | $255 |
| Ultrasound scan of pelvic region through rectum | 54 | $25 | $38 |
| Office visit, established patient, complex (40-54 min) | 47 | $148 | $184 |
| Drug injection, under skin or into muscle | 45 | $11 | $15 |
| Simple bladder irrigation and/or instillation | 44 | $63 | $79 |
| Ultrasonic guidance for needle placement | 44 | $25 | $34 |
| Initial hospital admission, high complexity | 43 | $135 | $197 |
| Office visit, established patient (20-29 min) | 39 | $65 | $98 |
| Complete ultrasound scan behind abdominal cavity | 35 | $57 | $82 |
| Waterjet destruction of prostrate accessed through the urethra | 29 | $571 | $1,799 |
| Injection procedure to cause erection | 24 | $72 | $93 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 24 | $23 | $35 |
| Hospital follow-up visit, moderate complexity | 23 | $65 | $85 |
| Simple insertion of temporary bladder tube | 18 | $51 | $64 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 13 | $594 | $750 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (51%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 10% for urology physician in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Goldfarb is a clinical cardiology specialist, with above-average Medicare volume (top 19% in TX), with speaking/promotional industry engagement in the top 10% of TX peers, with 16 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Goldfarb experienced with chronic care management, first 20 min/month?
Does Dr. Goldfarb receive payments from pharmaceutical companies?
How do Dr. Goldfarb's costs compare to other urology physicians in Houston?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology